宏遠 1460 - 股息配發率

現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: 33.33%
要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)

	EPS YoY		現金股利 YoY		股票股利 YoY		現金配發率 YoY		股票配發率 YoY		全部配發率 YoY
2023 (10)	-1.80	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0
2022 (9)	0.03	-92.31	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0
2021 (8)	0.39	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0
2020 (7)	-1.94	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0
2019 (6)	-0.56	0	0.00	0	0.00	0	0.00	0	0.00	0	0.00	0
2018 (5)	0.33	-29.79	0.00	0	0.20	0.0	0.00	0	60.61	42.42	60.61	42.42
2017 (4)	0.47	-60.83	0.00	0	0.20	-50.0	0.00	0	42.55	27.66	42.55	-36.17
2016 (3)	1.20	16.5	0.40	-50.0	0.40	0	33.33	-57.08	33.33	0	66.67	-14.17

每股盈餘-近20季

	EPS QoQ YoY			本業EPS QoQ YoY			累計EPS QoQ YoY
23Q4 (20)	-0.96	-45.45	-265.52	-0.85	-28.79	-2933.33	-1.80	-114.29	-6100.0
23Q3 (19)	-0.66	-266.67	-1220.0	-0.66	-214.29	-371.43	-0.84	-394.12	-55.56
23Q2 (18)	-0.18	-1900.0	-400.0	-0.21	-290.91	-800.0	-0.17	-1800.0	65.31
23Q1 (17)	0.01	-98.28	101.82	0.11	266.67	22.22	0.01	-66.67	101.82
22Q4 (16)	0.58	1260.0	262.5	0.03	121.43	-76.92	0.03	105.56	-92.31
22Q3 (15)	-0.05	-183.33	-145.45	-0.14	-566.67	-300.0	-0.54	-10.2	-300.0
22Q2 (14)	0.06	110.91	-45.45	0.03	-66.67	-70.0	-0.49	10.91	-406.25
22Q1 (13)	-0.55	-443.75	-1475.0	0.09	-30.77	12.5	-0.55	-241.03	-1475.0
21Q4 (12)	0.16	45.45	113.45	0.13	85.71	118.06	0.39	44.44	120.1
21Q3 (11)	0.11	0.0	450.0	0.07	-30.0	75.0	0.27	68.75	136.0
21Q2 (10)	0.11	175.0	123.91	0.10	25.0	127.78	0.16	300.0	120.78
21Q1 (9)	0.04	103.36	112.9	0.08	111.11	134.78	0.04	102.06	112.9
20Q4 (8)	-1.19	-6050.0	-170.45	-0.72	-1900.0	-278.95	-1.94	-158.67	-246.43
20Q3 (7)	0.02	104.35	111.76	0.04	111.11	157.14	-0.75	2.6	-476.92
20Q2 (6)	-0.46	-48.39	-4700.0	-0.36	-56.52	0	-0.77	-148.39	-2025.0
20Q1 (5)	-0.31	29.55	-1133.33	-0.23	-21.05	-1250.0	-0.31	44.64	-1133.33
19Q4 (4)	-0.44	-158.82	0.0	-0.19	-171.43	0.0	-0.56	-330.77	0.0
19Q3 (3)	-0.17	-1800.0	0.0	-0.07	0	0.0	-0.13	-425.0	0.0
19Q2 (2)	0.01	-66.67	0.0	-0.00	-100.0	0.0	0.04	33.33	0.0
19Q1 (1)	0.03	0.0	0.0	0.02	0.0	0.0	0.03	0.0	0.0

年/月	營收	月增率(%)	去年同期年增率(%)	累計營收	累計營收年增率(%)	近三月累計營收	存貨銷售比	備註(年增率變動50%需說明原因)
2024/3	6.03	-6.82	-9.89	19.33	0.32	19.34	N/A	-
2024/2	6.47	-5.31	0.38	13.3	5.7	20.29	N/A	-
2024/1	6.84	-2.1	11.32	6.84	11.32	22.17	N/A	-
2023/12	6.98	-16.41	-0.51	78.39	-20.07	22.84	2.18	-
2023/11	8.35	11.35	3.8	71.42	-21.57	23.06	2.16	-
2023/10	7.5	4.14	8.38	63.06	-24.03	21.36	2.34	-
2023/9	7.2	8.26	-20.36	55.55	-26.98	20.23	2.88	-
2023/8	6.65	4.4	-28.12	48.36	-27.85	18.85	3.09	-
2023/7	6.37	9.41	-23.72	41.71	-27.81	17.71	3.29	-
2023/6	5.82	5.67	-29.42	35.33	-28.5	16.07	3.82	-
2023/5	5.51	16.37	-27.19	29.51	-28.32	16.94	3.63	-
2023/4	4.74	-29.23	-34.61	24.0	-28.52	17.88	3.44	-
2023/3	6.69	3.81	-30.24	19.27	-26.85	19.28	3.15	-
2023/2	6.45	5.0	-20.23	12.58	-24.85	19.61	3.1	-
2023/1	6.14	-12.52	-29.11	6.14	-29.11	21.21	2.87	-
2022/12	7.02	-12.78	-32.34	98.08	-1.98	21.99	2.8	-
2022/11	8.05	16.26	-23.55	91.06	1.51	24.02	2.56	-
2022/10	6.92	-23.48	-31.18	83.01	4.83	25.23	2.44	-
2022/9	9.05	-2.27	-4.8	76.08	10.07	26.66	2.24	-
2022/8	9.26	10.79	0.59	67.03	12.44	25.87	2.31	-
2022/7	8.36	1.23	20.63	57.77	14.62	24.12	2.48	-
2022/6	8.25	9.91	14.56	49.36	13.52	23.0	2.51	-
2022/5	7.51	3.66	0.87	41.11	13.35	24.35	2.37	-
2022/4	7.24	-24.51	-2.18	33.59	16.5	24.92	2.32	-
2022/3	9.59	18.7	30.85	26.34	22.97	26.34	2.13	-
2022/2	8.08	-6.67	30.94	16.75	18.83	27.12	2.07	-
2022/1	8.66	-16.5	9.35	8.66	9.35	29.56	1.9	-
2021/12	10.37	-1.46	35.67	100.07	36.25	30.96	1.85	-
2021/11	10.53	4.66	23.97	89.7	36.32	30.09	1.9	-
2021/10	10.06	5.87	17.17	79.18	38.16	28.76	1.99	-
2021/9	9.5	3.23	39.77	69.12	41.85	25.63	2.17	-
2021/8	9.2	32.86	53.21	59.61	42.17	23.33	2.38	業績成長
2021/7	6.93	-3.85	24.59	50.4	40.31	21.57	2.57	-
2021/6	7.2	-3.21	58.3	43.48	43.19	22.05	2.31	109年因疫情影響造成營收減少
2021/5	7.44	0.52	101.31	36.27	40.56	22.18	2.3	109年因疫情影響造成營收減少
2021/4	7.4	0.98	118.32	28.83	30.42	20.91	2.43	109年因疫情影響造成營收減少
2021/3	7.33	18.79	12.5	21.42	14.49	21.43	2.23	-
2021/2	6.17	-22.06	5.49	14.09	15.59	21.63	2.21	-
2021/1	7.92	5.08	24.89	7.92	24.89	23.95	2.0	-
2020/12	7.54	-11.23	-7.98	73.33	-17.27	24.61	1.89	-
2020/11	8.49	-1.05	9.67	65.8	-18.21	23.87	1.95	-
2020/10	8.58	26.3	0.48	57.31	-21.17	21.38	2.18	-
2020/9	6.79	13.12	-23.33	48.72	-24.06	18.36	2.78	-
2020/8	6.01	8.13	-16.23	41.92	-24.19	16.01	3.19	-
2020/7	5.55	24.88	0.16	35.92	-25.38	13.7	3.72	-
2020/6	4.45	20.29	-28.91	30.37	-28.68	11.54	4.11	-
2020/5	3.7	9.01	-42.8	25.8	-28.98	13.61	3.49	-
2020/4	3.39	-48.01	-53.83	22.1	-26.0	15.77	3.01	受疫情影響
2020/3	6.52	11.5	-18.07	18.72	-16.88	18.72	2.56	-
2020/2	5.85	-7.73	-4.43	12.19	-16.27	20.38	2.35	-
2020/1	6.34	-22.57	-24.79	6.34	-24.79	22.28	2.15	-
2019/12	8.19	5.79	-5.02	88.64	-5.76	24.47	1.94	-
2019/11	7.74	-9.34	-11.07	80.45	-5.83	25.15	1.89	-
2019/10	8.54	-3.63	-7.02	72.7	-5.24	24.57	1.93	-
2019/9	8.86	23.59	2.01	64.16	-5.0	21.58	2.27	-
2019/8	7.17	29.31	-7.44	55.3	-6.03	18.97	2.59	-
2019/7	5.54	-11.37	-4.91	48.13	-5.81	18.27	2.69	-
2019/6	6.26	-3.21	-2.87	42.59	-5.93	20.07	2.39	-
2019/5	6.46	-12.01	-15.12	36.34	-6.43	0.0	N/A	-
2019/4	7.35	-7.64	-2.1	29.87	-4.3	0.0	N/A	-